Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-21-000839
Filing Date
2021-01-27
Accepted
2021-01-27 16:33:18
Documents
1
Period of Report
2021-01-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 6845
  Complete submission text file 0001654954-21-000839.txt   8558
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY, SUITE 490 MORRISVILLE NC 27560
Business Address
Rich Stuart (Reporting) CIK: 0001841785 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34600 | Film No.: 21560222